Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Deacylated Ghrelin and Beta Cell Function (UAG)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by University of Cincinnati.
Recruitment status was  Active, not recruiting
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
David Dalessio, University of Cincinnati Identifier:
First received: February 8, 2012
Last updated: November 13, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)